Paper38515134
CTLs heterogeneity and plasticity: implications for cancer immunotherapy.
Peng S and 7 others. Mol Cancer, 2024. Cited by 102 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. CTLs heterogeneity and plasticity: implications for cancer immunotherapy. Papers, record 38515134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38515134
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| T-Lymphocytes, Cytotoxic | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Epigenesis, Genetic | |
| Immunotherapy | |
| Biomarkers |
Source PubMed
References163
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,636,719 | The oral cancer microbiome contains tumor space-specific and clinicopathology-specific bacteria. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36636719 | PubMed |
| 2 | 24,586,481 | Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24586481 | PubMed |
| 3 | 25,387,013 | Comparative biology of γδ T cell function in humans, mice, and domestic animals. | Annu Rev Anim Biosci | 2013 | https://conductscience.org/library/papers/25387013 | PubMed |
| 4 | 35,572,552 | The Era of Cytotoxic CD4 T Cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/35572552 | PubMed |
| 5 | 33,526,861 | EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia. | Leukemia | 2021 | https://conductscience.org/library/papers/33526861 | PubMed |
| 6 | 34,681,881 | Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34681881 | PubMed |
| 7 | 35,086,948 | CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35086948 | PubMed |
| 8 | 36,599,469 | Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. | J Immunother Cancer | 2023 | https://conductscience.org/library/papers/36599469 | PubMed |
| 9 | 27,670,945 | Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli. | Innate Immun | 2016 | https://conductscience.org/library/papers/27670945 | PubMed |
| 10 | 28,709,825 | The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity. | Trends Immunol | 2017 | https://conductscience.org/library/papers/28709825 | PubMed |
| 11 | 37,202,206 | Murine cytotoxic CD4+ T cells in the tumor microenvironment are at a hyper-maturation stage of Th1 CD4+ T cells sustained by IL-12. | Int Immunol | 2023 | https://conductscience.org/library/papers/37202206 | PubMed |
| 12 | 19,904,767 | Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis. | Eur J Immunol | 2010 | https://conductscience.org/library/papers/19904767 | PubMed |
| 13 | 36,937,426 | Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1. | Front Oncol | 2023 | https://conductscience.org/library/papers/36937426 | PubMed |
| 14 | 2,022,921 | Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. | J Exp Med | 1991 | https://conductscience.org/library/papers/2022921 | PubMed |
| 15 | 18,219,309 | Shaping and reshaping CD8+ T-cell memory. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18219309 | PubMed |
| 16 | 27,809,856 | T cells in multiple myeloma display features of exhaustion and senescence at the tumor site. | J Hematol Oncol | 2016 | https://conductscience.org/library/papers/27809856 | PubMed |
| 17 | 32,870,971 | The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma. | Blood Adv | 2020 | https://conductscience.org/library/papers/32870971 | PubMed |
| 18 | 28,898,397 | Genome-wide DNA methylation analysis of senescence in repetitively infected memory cytotoxic T lymphocytes. | Immunology | 2018 | https://conductscience.org/library/papers/28898397 | PubMed |
| 19 | 36,796,366 | OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/36796366 | PubMed |
| 20 | 15,556,688 | The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. | Hum Immunol | 2004 | https://conductscience.org/library/papers/15556688 | PubMed |
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,982,946 | Pulsed Low-dose-rate Radiotherapy Remodels the Tumor Immune Microenvironment and is Associated With Crosstalk Between SPP1⁺ tumor-associated macrophages and GZMK⁺ CD8⁺ T cells. | Cell Biol Toxicol | 2026 | https://conductscience.org/library/papers/42982946 | PubMed |
| 42,979,333 | Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42979333 | PubMed |
| 42,724,447 | Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724447 | PubMed |
| 42,538,571 | Fatty acid metabolism in glioma: a review of novel targets and therapeutic strategies. | Chin Neurosurg J | 2026 | https://conductscience.org/library/papers/42538571 | PubMed |
| 42,523,842 | Immune-epigenetic-metabolic crosstalk: attempting to unravel the multidimensional mechanisms of immune evasion in endometriosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42523842 | PubMed |
| 42,388,313 | Research progress on T-cell responses in Staphylococcus aureus infections. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42388313 | PubMed |
| 42,304,928 | Exploring the Tumor Microenvironment: Immuno-Genotoxic Biomarkers at the Forefront of Cancer Diagnosis and Therapy. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/42304928 | PubMed |
| 42,266,746 | BANF1 knockdown impedes thyroid cancer development and boosts CD8+ T cell activity through PI3K/AKT/mTOR pathway. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42266746 | PubMed |
| 42,221,415 | Glucagon-like Peptide-1 Receptor Agonists and Colorectal Cancer Risk. | AACE Endocrinol Diabetes | 2026 | https://conductscience.org/library/papers/42221415 | PubMed |
| 42,151,232 | Nanoplastics impair antitumor NK and CD8⁺ T cell cytotoxicity and antiviral B cell antibody responses to SARS-CoV-2. | Sci Rep | 2026 | https://conductscience.org/library/papers/42151232 | PubMed |
| 42,105,153 | Precision oncology in gastric cancer: navigating molecular subtypes, therapeutic targets, and future horizons. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/42105153 | PubMed |
| 42,103,355 | LGALS9 blockade augments vaccine-induced immune responses against prostate cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42103355 | PubMed |
| 41,956,548 | Second primary cancers following hematologic malignancies: Epidemiology, pathobiology and clinical management. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41956548 | PubMed |
| 41,854,744 | Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway. | J Mol Med (Berl) | 2026 | https://conductscience.org/library/papers/41854744 | PubMed |
| 41,803,090 | Cytotoxic CD4+ T cells: origin, biological functions, diseases and therapeutic targets. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41803090 | PubMed |
| 41,766,862 | Beyond the Th2 paradigm: CD4+ cytotoxic T lymphocytes as key drivers of tissue damage and fibrosis in IgG4-related disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/41766862 | PubMed |
| 41,738,042 | Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/41738042 | PubMed |
| 41,681,793 | BCL2A1high CD8+ T Cells Are a Survival-Associated Predictor of Immune Checkpoint Blockade Response in Lung Adenocarcinoma. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41681793 | PubMed |
| 41,664,229 | Semaphorins: from CD8⁺ T cells to cancer immunotherapy. | Biomark Res | 2026 | https://conductscience.org/library/papers/41664229 | PubMed |
| 41,625,477 | Tumor Microenvironment Onmyoji: Cytokines with Dual Protumor and Antitumor Roles. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/41625477 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| PRDM1 | 639 | PubTator's text mining | https://conductscience.org/library/genes/639 | NCBI Gene |
| TBX21 | 30,009 | PubTator's text mining | https://conductscience.org/library/genes/30009 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38515134
GET https://conductscience.org/api/papers/v1/38515134/references?page=2